---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-012560"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T09:02:39.630520+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech appoints Seth Yon as CEO; Nixon remains Executive Chairman

## Summary
- Seth Yon promoted from President/Chief Commercial Officer to President/CEO and director, effective Sept 15, 2025.
- Ron Nixon resigns as CEO but remains Executive Chairman; receives director retainer ($90K stock + $40K cash) plus $100K cash for Chairman role.
- Yon employment agreement: $600K base salary, up to 100% bonus/stock awards, plus $1M one-time restricted stock grant vesting over 3 years.
- Ashley Mackey designated principal accounting officer; Elizabeth Taylor remains CFO but no longer principal accounting officer.

## SEC filing metadata
- accession: 0001493152-25-012560
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315225012560/0001493152-25-012560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315225012560/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-012560
- JSON: https://secwatch.observer/filing/0001493152-25-012560.json
- Plain text: https://secwatch.observer/filing/0001493152-25-012560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.